These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 555754)

  • 1. Biochemical effects of niridazole. I. In vitro and in vivo effect of niridazole on the rate of gluconeogenesis and oxidation of pyruvate and some Krebs cycle intermediates in mice.
    Sharaf AA; Khayyal MT; Kheir-el-Din A; Sharaf AA; Kassem F
    Egypt J Bilharz; 1978; 5(1-2):49-57. PubMed ID: 555754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical effects of niridazole. II. In vitro and in vivo effects of niridazole on the rate of gluconeogenesis and the rate of oxidation of pyruvate and some Krebs cycle intermediates in Schistosoma mansoni infected mice.
    Sharaf AA; Khayyal MT; Kheir-el-Din A; Sharaf AA; Kassem F
    Egypt J Bilharz; 1978; 5(1-2):59-69. PubMed ID: 555755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A mathematical model of the pyruvate oxidation in liver mitochondria. 1. Regulation of the Krebs cycle by adenine and pyridine nucleotides].
    Dynnik VV; Temnov AV
    Biokhimiia; 1977 Jun; 42(6):1030-44. PubMed ID: 196685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration in pyruvate metabolism in the liver of tumor-bearing rats.
    Shearer JD; Buzby GP; Mullen JL; Miller E; Caldwell MD
    Cancer Res; 1984 Oct; 44(10):4443-6. PubMed ID: 6467203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nicotinamide as an inhibitor of gluconeogenesis from pyruvate in perfused rat liver].
    Velikiĭ NN; Khalmuradov AG; Parkhomets PK; Chagovets RV
    Dokl Akad Nauk SSSR; 1980; 250(4):992-5. PubMed ID: 6445256
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of niridazole on the lipid pattern of the parasite and host tissues in experimental schistosomiasis mansoni.
    Khayyal MT; Mousa AH; Saleh S; Abo-HASHISH MA; Metwally AA
    Egypt J Bilharz; 1978; 4(1):89-96. PubMed ID: 648459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the inhibition of gluconeogenesis by biguanides in the perfused guinea pig liver.
    Haeckel R; Haeckel H
    Hoppe Seylers Z Physiol Chem; 1970 Mar; 351(3):288-9. PubMed ID: 5420695
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibition of gluconeogenesis in the kidneys by a cytoplasmic regulator of mitochondrial membrane permeability].
    Turakulov IaKh; Gizatullina ZZ; Gaĭnutdinov MKh; Guliamov TD
    Biull Eksp Biol Med; 1981 Mar; 91(3):322-4. PubMed ID: 7018616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelation between the effects of ethanol and thyroid hormones on gluconeogenesis from alanine in perfused rat liver.
    Singh SP; Snyder AK
    J Lab Clin Med; 1982 May; 99(5):746-53. PubMed ID: 7069271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic conversion of pyruvate in the liver in experimental burns].
    Slobodin VB
    Vopr Med Khim; 1981; 27(4):496-500. PubMed ID: 7293081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic basis of aminonucleoside nephrosis in rats. II. Inhibition of renal gluconeogenesis by aminonucleoside.
    Yoshida T; Metcoff J
    J Lab Clin Med; 1968 Oct; 72(4):576-81. PubMed ID: 5677305
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle. I. Interrelation between gluconeogenesis and cataplerosis; formation of methoxamates from aminooxyacetate and ketoacids.
    Yang L; Kombu RS; Kasumov T; Zhu SH; Cendrowski AV; David F; Anderson VE; Kelleher JK; Brunengraber H
    J Biol Chem; 2008 Aug; 283(32):21978-87. PubMed ID: 18544527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The formation of pyruvate from citric acid-cycle intermediates in kidney cortex [proceedings].
    Watford M; Vinay P; Lemieux G; Gougoux A
    Biochem Soc Trans; 1979 Aug; 7(4):753-5. PubMed ID: 478151
    [No Abstract]   [Full Text] [Related]  

  • 14. Rate-limiting factors in the utilization of pyruvate for gluconeogenesis in rabbit hepatocytes.
    Zaleski J; Bryła J
    Int J Biochem; 1979; 10(3):241-6. PubMed ID: 428631
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the levels of glycolysis and tricarboxylic acid cycle metabolites in cat tissues during periodontosis].
    Pakhomova VA; Kriukova GN; Pakhomova OO
    Ukr Biokhim Zh (1978); 1985; 57(1):70-3. PubMed ID: 3976017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate Carboxylase Wields a Double-Edged Metabolic Sword.
    Hughey CC; Crawford PA
    Cell Metab; 2019 Jun; 29(6):1236-1238. PubMed ID: 31167118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pyruvate oxidation and S35-lipoic acid fixation by breast tumor homogenates].
    Savvov VI; Karpov LM
    Vopr Onkol; 1978; 24(8):97-9. PubMed ID: 211729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenic effects of niridazole in animal-mediated and in liquid suspension assays using Escherichia coli K-12 as an indicator.
    Knasmüller S; Szakmary A
    Mutat Res; 1992 Aug; 280(2):93-101. PubMed ID: 1378543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice.
    Legator MS; Connor TH; Stoeckel M
    Science; 1975 Jun; 188(4193):1118-9. PubMed ID: 766186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of niridazole and niridazole immunoregulatory factor (NIF) on cutaneous delayed hypersensitivity in mice.
    Blumer JL; Simpson JM; Lucas SV; Webster LT
    Immunopharmacology; 1979 Dec; 2(1):51-61. PubMed ID: 553082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.